Form 4 for CORZ Core Scientific, Inc./tx
Accepted 2024-08-20 00:00:00 ET · period of report 2024-08-16 · accession 0000905148-24-002307 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-20 | 2024-08-16 | CORZ | Sullivan Adam Taylor | CEO, Dir | X - OptEx | $0.01 | +95.3K | 4.06M | +2% | +$953.03 |
| D | 2024-08-20 | 2024-08-16 | CORZ | Sullivan Adam Taylor | CEO, Dir | X - OptEx | $0.00 | -95.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-16 | X | A | 95,303 | $0.01 | 4,057,579 | D | — | — | |
| 2 | Derivative | Tranche 2 Warrants | 2024-08-16 | X | D | 95,303 | $0.00 | 0 | D | $0.01 · — to 2029-01-23 | 95,303 Common Stock | (F1) The Reporting Person received 95,303 Tranche 2 Warrants on April 3, 2024 for no consideration in connection with an in-kind distribution by XMS Capital Partners, LLC, which acquisition was exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16a-9 under the Exchange Act. (F2) Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of the Issuer's common stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days, subject to certain adjustments. The Tranche 2 Warrants became exercisable at the option of the registered holders on July 11, 2024. |